newsfilter
← Latest News
Business Wire·

David Gao Confirms Lawsuit Against China Biologic Products to Protect Shareholders’ Best Interests

BEIJING--(BUSINESS WIRE)--Mr. David (Xiaoying) Gao, a shareholder of China Biologic Products Holdings, Inc. (“China Biologic” or the “Company”) (NASDAQ: CBPO), today confirmed that he filed a lawsuit against the Company related to its private placement of shares to a select investor group – including a private equity firm formed by Board Chairman David Li.